Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Absence of SARM1 Rescues Development and Survival of NMNAT2-Deficient Axons
Jonathan Gilley, Giuseppe Orsomando, Isabel Nascimento-Ferreira, et al.
Cell Reports (2015) Vol. 10, Iss. 12, pp. 1974-1981
Open Access | Times Cited: 185

Showing 1-25 of 185 citing articles:

NAD+ metabolism and its roles in cellular processes during ageing
Anthony J. Covarrubias, Rosalba Perrone, Alessia Grozio, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 22, Iss. 2, pp. 119-141
Open Access | Times Cited: 947
Neuronal Cell Death
Michael Fricker, Aviva M. Tolkovsky, Vilmantė Borutaitė, et al.
Physiological Reviews (2018) Vol. 98, Iss. 2, pp. 813-880
Open Access | Times Cited: 916
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Luis A. Rajman, Karolina Chwalek, David Sinclair
Cell Metabolism (2018) Vol. 27, Iss. 3, pp. 529-547
Open Access | Times Cited: 703
Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism
Josiah Gerdts, Daniel W. Summers, Jeffrey Milbrandt, et al.
Neuron (2016) Vol. 89, Iss. 3, pp. 449-460
Open Access | Times Cited: 310
Traumatic Axonal Injury: Mechanisms and Translational Opportunities
Ciaran Scott Hill, Michael P. Coleman, David Menon
Trends in Neurosciences (2016) Vol. 39, Iss. 5, pp. 311-324
Open Access | Times Cited: 275
Programmed axon degeneration: from mouse to mechanism to medicine
Michael P. Coleman, Ahmet Höke
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 4, pp. 183-196
Open Access | Times Cited: 258
SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration
Matthew D. Figley, Weixi Gu, Jeffrey D. Nanson, et al.
Neuron (2021) Vol. 109, Iss. 7, pp. 1118-1136.e11
Open Access | Times Cited: 255
Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice
Stefanie Geisler, Ryan A. Doan, Amy Strickland, et al.
Brain (2016) Vol. 139, Iss. 12, pp. 3092-3108
Open Access | Times Cited: 243
The Axon-Myelin Unit in Development and Degenerative Disease
Ruth M. Stassart, Wiebke Möbius, Klaus‐Armin Nave, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 217
NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ depletion
Yo Sasaki, Takashi Nakagawa, Xianrong Mao, et al.
eLife (2016) Vol. 5
Open Access | Times Cited: 192
A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy
Yusuke Fukuda, Yihang Li, Rosalind A. Segal
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 190
The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative SARM1
Yuefeng Jiang, Tingting Liu, Chia‐Hsueh Lee, et al.
Nature (2020) Vol. 588, Iss. 7839, pp. 658-663
Closed Access | Times Cited: 161
SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites
Carlo Alberto Angeletti, Adolfo Amici, Jonathan Gilley, et al.
iScience (2022) Vol. 25, Iss. 2, pp. 103812-103812
Open Access | Times Cited: 70
Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering
James R. Tribble, Flora Hui, Heberto Quintero, et al.
Molecular Aspects of Medicine (2023) Vol. 92, pp. 101193-101193
Open Access | Times Cited: 54
Targeting synapse function and loss for treatment of neurodegenerative diseases
Borislav Dejanovic, Morgan Sheng, Jesse E. Hanson
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 23-42
Closed Access | Times Cited: 41
Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy
Elliot Turkiew, Debbie Falconer, Nicole Reed, et al.
Journal of the Peripheral Nervous System (2017) Vol. 22, Iss. 3, pp. 162-171
Open Access | Times Cited: 160
MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2
Lauren J. Walker, Daniel W. Summers, Yo Sasaki, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 140
Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program
Stefanie Geisler, Ryan A. Doan, Galen Cheng, et al.
JCI Insight (2019) Vol. 4, Iss. 17
Open Access | Times Cited: 132
SARM1-specific motifs in the TIR domain enable NAD + loss and regulate injury-induced SARM1 activation
Daniel W. Summers, Daniel Gibson, Aaron DiAntonio, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 41
Open Access | Times Cited: 125
Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca 2+ Influx but Only Modestly Influenced by Mitochondria
Andrea Loreto, M. Di Stefano, Martin Gering, et al.
Cell Reports (2015) Vol. 13, Iss. 11, pp. 2539-2552
Open Access | Times Cited: 122
Gene therapy targeting SARM1 blocks pathological axon degeneration in mice
Stefanie Geisler, Shay X. Huang, Amy Strickland, et al.
The Journal of Experimental Medicine (2019) Vol. 216, Iss. 2, pp. 294-303
Open Access | Times Cited: 122
Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain
Ksenia Kurbatskaya, Emma Claire Phillips, Cara L. Croft, et al.
Acta Neuropathologica Communications (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 119
SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration
Kwang Woo Ko, Jeffrey Milbrandt, Aaron DiAntonio
The Journal of Cell Biology (2020) Vol. 219, Iss. 8
Open Access | Times Cited: 116
The SARM1 axon degeneration pathway: control of the NAD+ metabolome regulates axon survival in health and disease
Matthew D. Figley, Aaron DiAntonio
Current Opinion in Neurobiology (2020) Vol. 63, pp. 59-66
Open Access | Times Cited: 115
Sarm1 Deletion, but Not Wld S , Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy
Jonathan Gilley, Richard R. Ribchester, Michael P. Coleman
Cell Reports (2017) Vol. 21, Iss. 1, pp. 10-16
Open Access | Times Cited: 113
Page 1 - Next Page

Scroll to top